Management of anorexia and bulimia nervosa: An evidence-based review

Kaustav Chakraborty, Debasish Basu, Kaustav Chakraborty, Debasish Basu

Abstract

Anorexia nervosa and bulimia nervosa are primarily psychiatric disorders characterized by severe disturbances of eating behavior. Eating disorders are most prevalent in the Western culture where food is in abundance and female attractiveness is equated with thinness. Eating disorders are rare in countries like India. Despite a plethora of management options available to the mental health professionals, no major breakthrough has been achieved in recent years. Nutritional rehabilitation along with some form of re educative psychotherapy remains the mainstay of management of anorexia nervosa. In bulimia nervosa, both fluoxetine and cognitive behavior therapy have been found to be effective. Although the above-mentioned management options have been in use for decades, the active ingredient is still to be ascertained.

Keywords: Anorexia nervosa; behavioural interventions; bulimia; eating disorder; management; medications; psychotherapy.

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Fairburn CG, Walsh BT. Atypical eating disorders (Eating disorder not otherwise specified). Eating disorders and obesity: A comprehensive handbook. In: Fairburn, Brownell, editors. London: Guilford; 2002. pp. 171–7.
    1. Hoek HW, van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord. 2003;34:383–96.
    1. Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry. 2002;159:1284–93.
    1. Herzog DB, Nussbaum KM, Marmor AK. Comorbidity and outcome in eating disorders. Psychiatr Clin North Am. 1996;19:843–59.
    1. Herpertz-Dahlmann B, Muller B, Herpertz S, Heussen N, Hebebrand J, Remschmidt H. Prospective 10-year follow-up in adolescent anorexia nervosa-course, outcome, psychiatric comorbidity, and psychosocial adaptation. J Child Psychol Psychiatry. 2001;42:603–12.
    1. Keel PK, Mitchell JE. Outcome in bulimia nervosa. Am J Psychiatry. 1997;154:313–21.
    1. Hsu LK, Sobkiewicz TA. Bulimia nervosa: A four-to six-year follow-up study. Psychol Med. 1989;19:1035–8.
    1. Patel DR, Phillips EL, Pratt HD. Eating disorders. Indian J Pediatr. 1998;65:487–94.
    1. Khandelwal SK, Sharan P, Saxena S. Eating disorders: An Indian perspective. Int J Soc Psychiatry. 1995;41:132–46.
    1. Fairburn CG, Cooper Z, Doll HA, Norman P, O’Connor M. The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry. 2000;57:659–65.
    1. Hoek HW, Vandereycken W. Eating disorders: 25 years of research and treatment. Tijdschr Psychiatr. 2008;50:85–9.
    1. Kaplan AS, Garfinkel PE. Difficulties in treating patients with eating disorders: A review of patient and clinician variables. Can J Psychiatry. 1999;44:665–70.
    1. Feld R, Woodside DB, Kaplan AS, Olmsted MP, Carter JC. Pretreatment motivational enhancement therapy for eating disorders: A pilot study. Int J Eat Disord. 2001;29:393–400.
    1. Geller J, Williams K, Srikameswaran S. Clinician stance in the treatment of chronic eating disorders. Eur Eating Disorders Rev. 2001;9:1–9.
    1. Vitousek K, Watson S, Wilson GT. Enhancing motivation for change in treatment-resistant eating disorders. Clin Psychol Rev. 1998;18:391–420.
    1. Fairburn CG, Cooper Z. The eating disorder examination. In: Fairburn CG, Wilson GT, editors. Binge eating: Nature, assessment and treatment. 12th ed. New York: Guilford; 1993. pp. 317–60.
    1. Mazure CM, Halmi KA, Sunday SR, Romano SJ, Einhorn AM. The Yale-Brown-Cornell eating disorder scale: Development, use, reliability and validity. J Psychiatr Res. 1994;28:425–45.
    1. Sunday SR, Halmi KA, Einhorn A. The Yale-Brown-Cornell eating disorder scale: A new scale to assess eating disorder symptomatology. Int J Eat Disord. 1995;18:237–45.
    1. Johnson C. Diagnostic Survey for Eating Disorders (DSED), in the etiology and treatment of bulimia nervosa. In: Johnson C, Connors M, editors. Biopsychosocial perspective. New York: Basic Books; 1987. pp. 174–94.
    1. Thelen MH, Mintz LB, Vander Wal JS. The Bulimia Test, revised: Validation with DSM-IV criteria for bulimia nervosa. Psychol Assess. 1996;8:219–21.
    1. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test: Psychometric features and clinical correlates. Psychol Med. 1982;12:871–8.
    1. Fairburn CG, Beglin SJ. Assessment of eating disorders: Interview or self-report questionnaire? Int J Eat Disord. 1994;16:363–70.
    1. Garner DM, Olmstead MJ, Polivy J. Development and validation of a multidimensional eating disorder inventory for anorexia nervosa and bulimia. Int J Eat Disord. 1983;2:15–34.
    1. Garner DM. The eating disorders inventory-2.Professional manual Odessa, FL. Psychological Assessment Resources. 1991
    1. Birmingham CL, Beumont PJV. Medical management of eating disorders. Cambridge, UK: Cambridge University Press; 2004. A Practical Handbook for Healthcare Professionals.
    1. Mehler PS, Andersen AE. A guide to medical care and complications. Baltimore: Johns Hopkins University Press; 1999. Eating disorders.
    1. Miller KK, Grinspoon SK, Ciampa J, Hier J, Herzog D, Klibanski A. Medical findings in outpatients with anorexia nervosa. Arch Intern Med. 2005;165:561–6.
    1. Golden NH, Jacobson MS, Schebendach J, Solanto MV, Hertz SM, Shenker IR. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med. 1997;151:16–21.
    1. Frisch RE, McArthur JW. Difference between postpartum and nutritional amenorrhea. Science. 1979;203:921–3.
    1. Frisch RE, McArthur JW. Menstrual cycles: Fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 1974;185:949–51.
    1. Katzman DK, Zipursky RB. Adolescents with anorexia nervosa: The impact of the disorder on bones and brains. Ann N Y Acad Sci. 1997;817:127–37.
    1. Golden NH, Meyer W. Nutritional rehabilitation of anorexia nervosa: Goals and dangers. Int J Adolesc Med Health. 2004;16:131–44.
    1. Kaye WH, Gwirtsman HE, Obarzanek E, George DT. Relative importance of calorie intake needed to gain weight and level of physical activity in anorexia nervosa. Am J Clin Nutr. 1988;47:989–94.
    1. American Psychiatric Association. Treatment of patients with eating disorders. Am J Psychiatric. (third edition) 2006;163:4–54.
    1. Golden NH, Jacobson MS, Schebendach J, Solanto MV, Hertz SM, Shenker IR. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med. 1997;151:16–21.
    1. Guarda AS, Heinberg LJ. Effective weight gain in step down partial hospitalization program for eating disorders. Paper presented at the annual meeting of the Academy for Eating Disorders. 1999:11–12. San Diego, June.
    1. Russel GF. Involuntary treatment in anorexia nervosa. Psychiatr Clin North Am. 2001;24:337–49.
    1. Beumont P, Hay P, Beumont D, Birmingham L, Derham H, Jordan A, et al. Australian and New Zealand clinical practice guidelines for the treatment of anorexia nervosa. Aust N Z J Psychiatry. 2004;38:659–70.
    1. Kaye WH, Weltzin TE, Hsu LK, Bulik CM. An open trial of fluoxetine in patients with anorexia nervosa. J Clin Psychiatry. 1991;52:464–71.
    1. Baran SA, Weltzin TE, Kaye WH. Low discharge weight and outcome in anorexia nervosa. Am J Psychiatry. 1995;152:1070–2.
    1. Watson TL, Bowers WA, Andersen AE. Involuntary treatment of eating disorders. Am J Psychiatry. 2000;157:1806–10.
    1. Attia E, Haiman C, Walsh BT, Flater SR. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry. 1998;155:548–51.
    1. Kaye W, Nagata T, Weltzin TE, Hsu LK, Sokol MS, McConaha C, et al. Double-blind placebo-controlled administration of fluoxetine in restricting-and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001;49:644–52.
    1. Fassino S, Leombruni P, Daga G, Brustolin A, Migliaretti G, Cavallo F, et al. Efficacy of citalopram in anorexia nervosa: A pilot study. Eur Neuropsychopharmacol. 2002;12:453–9.
    1. Halmi KA, Eckert E, LaDu TJ, Cohen J. Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry. 1986;43:177–81.
    1. Biederman J, Herzog D, Rivinus TM, Harper GP, Ferber RA, Rosenbaum JF, et al. Amitriptyline in the treatment of anorexia nervosa: A double-blind, placebo-controlled study. J Clin Psychopharmacol. 1985;5:10–6.
    1. Lacey JH, Crisp AH. Hunger, food intake and weight: The impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J. 1980;56:79–85.
    1. Claudino AM, Hay P, Lima MS, Bacaltchuk J, Schmidt U, Treasure J. Antidepressants for anorexia nervosa. Cochrane Database Syst Rev. 2006;1:CD004365.
    1. Barbarich NC, McConaha CW, Gaskill J, La VM, Frank GK, Achenbach S, et al. An open trial of olanzapine in anorexia nervosa. J Clin Psychiatry. 2004;65:1480–2.
    1. Malina A, Gaskill J, McConaha C, Frank GK, Lavia M, Scholar L, et al. Olanzapine treatment of anorexia nervosa: A retrospective study. Int J Eat Disord. 2003;33:234–7.
    1. Powers PS, Santana CA, Bannon YS. Olanzapine in the treatment of anorexia nervosa: An open label trial. Int J Eat Disord. 2002;32:146–54.
    1. Kaye WH. Applications symposium. New York: 2004. Atypicals in the treatment of anorexia nervosa. Paper presented at the Broadening the Horizon of Atypical Antipsychotic; p. 2004. Available from: [last cited on 2009 Mar 12]
    1. Bosanac P, Norman T, Burrows G, Beumont P. Serotonergic and dopaminergic systems in anorexia nervosa: A role for atypical antipsychotics? Aust N Z J Psychiatry. 2005;39:146–53.
    1. Powers PS, Bannon Y, Eubanks R. New York: Paper presented at the 157th annual meeting of the American Psychiatric Association; 4. Anorexia nervosa and quetiapine: effect on weight and psychopathology; pp. 1–6. May.
    1. Cassano GB, Miniati M, Pini S, Rotondo A, Banti S, Borri C, et al. Six month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: A preliminary report. Int J Eat Disord. 2003;33:172–7.
    1. Miller KK, Grieco KA, Klibanski A. Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab. 2005;90:1428–33.
    1. Hill K, Bucuvalas J, McClain C, Kryscio R, Martini RT, Alfaro MP, et al. Pilot study of growth hormone administration during the refeeding of malnourished anorexia nervosa patients. J Child Adolesc Psychopharmacol. 2000;10:3–8.
    1. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995;80:898–904.
    1. McElroy SL, Guerdjikova AI, Martens B, Keck PE, Jr, Pope HG, Hudson JI. Role of antiepileptic drugs in the management of eating disorders. CNS Drugs. 2009;23:139–56.
    1. Birmingham C, Goldner EM, Bakan R. Controlled trial of zinc supplementation in anorexia nervosa. Int J Eat Disord. 1994;15:251–5.
    1. Pike KM, Walsh BT, Vitousek K, Wilson GT, Bauer J. Cognitive behavior therapy in the posthospitalization treatment of anorexia nervosa. Am J Psychiatry. 2003;160:2046–9.
    1. McIntosh VV, Jordan J, Carter FA, Luty SE, McKenzie JM, Bulik CM, et al. Three psychotherapies for anorexia nervosa: A randomized, controlled trial. Am J Psychiatry. 2005;162:741–7.
    1. Channon S, de Silva P, Hemsley D, Perkins R. A controlled trial of cognitive-behavioural and behavioural treatment of anorexia nervosa. Behav Res Ther. 1989;27:529–35.
    1. Treasure J, Todd G, Brolly M, Tiller J, Nehmed A, Denman F. A pilot study of a randomised trial of cognitive analytical therapy vs educational behavioral therapy for adult anorexia nervosa. Behav Res Ther. 1995;33:363–7.
    1. Dare C, Eisler I, Russell G, Treasure J, Dodge L. Psychological therapies for adults with anorexia nervosa: Randomized controlled trial of out-patient treatments. Br J Psychiatry. 2001;178:216–21.
    1. Crisp AH, Norton K, Gowers S, Halek C, Bowyer C, Yeldham D, et al. A controlled study of the effect of therapies aimed at adolescent and family psychopathology in anorexia nervosa. Br J Psychiatry. 1991;159:325–33.
    1. Eisler I, Dare C, Hodes M, Russell G, Dodge E, Le Grange D. Family therapy for adolescent anorexia nervosa: The results of a controlled comparison of two family interventions. J Child Psychol Psychiatry. 2000;41:727–36.
    1. Geist R, Heinmaa M, Stephens D, Davis R, Katzman D. Comparison of family therapy and family group psychoeducation in adolescents with anorexia nervosa. Can J Psychiatry. 2000;45:173–8.
    1. Robin A, Siegel PT, Koepke T, Moye AW, Tice S. Family therapy versus individual therapy for adolescent females with anorexia nervosa. J Dev Behav Pediatr. 1994;15:111–6.
    1. Russell GF, Szmukler GI, Dare C, Eisler I. An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry. 1987;44:1047–56.
    1. Robin AL, Siegel PT, Moye A. Family versus individual therapy for anorexia: Impact on family conflict. Int J Eat Disord. 1995;17:313–22.
    1. Eisler I, Dare C, Russell GF, Szmukler G, le Grange D, Dodge E. Family and individual therapy in anorexia nervosa: A 5-year follow-up. Arch Gen Psychiatry. 1997;54:1025–30.
    1. Johnson CL, Taylor C. Working with difficult-to-treat eating disorders using an integration of twelve-step and traditional psychotherapies. Psychiatr Clin North Am. 1996;19:829–41.
    1. Hay P, Bacaltchuk J, Claudino A, Ben-Tovim D, Yong PY. Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa. Cochrane Database Syst Rev. 2003:CD003909.
    1. Gillberg C, Rastam M, Gillberg IC. Anorexia nervosa: Physical health and neurodevelopment at 16 and 21 years. Dev Med Child Neurol. 1994;36:567–75.
    1. Gillberg IC, Rastam M, Gillberg C. Anorexia nervosa outcome: Six-year controlled longitudinal study of 51 cases including a population cohort. J Am Acad Child Adolesc Psychiatry. 1994;33:729–39.
    1. Gillberg IC, Rastam M, Gillberg C. Anorexia nervosa 6 years after onset: Part I.Personality disorders. Compr Psychiatry. 1995;36:61–9.
    1. Rastam M, Gillberg C, Wentz E. Outcome of teenage-onset anorexia nervosa in a Swedish community-based sample. Eur Child Adolesc Psychiatry. 2003;12:I78–90.
    1. Wentz E, Gillberg C, Gillberg IC, Rastam M. Ten-year follow-up of adolescent-onset anorexia nervosa: Psychiatric disorders and overall functioning scales. J Child Psychol Psychiatry. 2001;42:613–22.
    1. Nilsson EW, Gillberg C, Gillberg IC, Rastam M. Ten-year followup of adolescent-onset anorexia nervosa: Personality disorders. J Am Acad Child Adolesc Psychiatry. 1999;38:1389–95.
    1. Halvorsen I, Andersen A, Heyerdahl S. Good outcome of adolescent onset anorexia nervosa after systematic treatment.Intermediate to long-term follow-up of a representative county-sample. Eur Child Adolesc Psychiatry. 2004;13:295–306.
    1. Strober M, Freeman R, Morrell W. The long-term course of severe anorexia nervosa in adolescents: Survival analysis of recovery, relapse, and outcome predictors over 10-15 years in a prospective study. Int J Eat Disord. 1997;22:339–60.
    1. Dancyger IF, Sunday SR, Eckert ED, Halmi KA. A comparative analysis of minnesota multiphasic personality inventory profiles of anorexia nervosa at hospital admission, discharge, and 10-year follow-up. Compr Psychiatry. 1997;38:185–91.
    1. Herzog DB, Field AE, Keller MB, West JC, Robbins WM, Staley J, et al. Subtyping eating disorders: Is it justified? J Am Acad Child Adolesc Psychiatry. 1996;35:928–36.
    1. Herzog DB, Dorer DJ, Keel PK, Selwyn SE, Ekeblad ER, Flores AT, et al. Recovery and relapse in anorexia and bulimia nervosa: A 7.5-year follow-up study. J Am Acad Child Adolesc Psychiatry. 1999;38:829–37.
    1. Isager T, Brinch M, Kreiner S, Tolstrup K. Death and relapse in anorexia nervosa: Survival analysis of 151 cases. J Psychiatr Res. 1985;19:515–21.
    1. Bruce B, Wilfley D. Binge eating among the overweight population: A serious and prevalent problem. J Am Diet Assoc. 1996;96:58–61.
    1. Eddy K, Keel PK, Dorer DJ, Delinsky SS, Franko DL, Herzog DB. Longitudinal comparison of anorexia nervosa subtypes. Int J Eat Disord. 2002;31:191–201.
    1. Patton GC. Mortality in eating disorders. Psychol Med. 1988;18:947–51.
    1. Keel PK, Dorer DJ, Eddy KT, Franko D, Charatan DL, Herzog DB. Predictors of mortality in eating disorders. Arch Gen Psychiatry. 2003;60:179–83.
    1. Herzog DB, Greenwood DN, Dorer DJ, Flores AT, Ekeblad ER, Richards A, et al. Mortality in eating disorders: A descriptive study. Int J Eat Disord. 2000;28:20–6.
    1. Franko DL, Keel PK, Dorer DJ, Blais MA, Delinsky SS, Eddy KT, et al. What predicts suicide attempts in women with eating disorders? Psychol Med. 2004;34:843–53.
    1. Pope HG, Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: A placebo-controlled, double-blind study. Am J Psychiatry. 1983;140:554–8.
    1. Beumont PJ, Russell JD, Touyz SW, Buckley C, Lowinger K, Talbot P, et al. Intensive nutritional counselling in bulimia nervosa: A role for supplementation with fluoxetine? Aust N Z J Psychiatry. 1997;31:514–24.
    1. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: A multicenter, placebo-controlled, double-blind trial. Arch Gen Psychiatry. 1992;49:139–47.
    1. Goldstein D, Wilson MG, Thompson VL, Potvin JH, Rampey AH., Jr Long-term fluoxetine treatment of bulimia nervosa: Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry. 1995;166:660–6.
    1. Romano SJ, Halmi KA, Sarkar NP, Koke SC, Lee JS. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry. 2002;159:96–102.
    1. Fichter MM, Leibl K, Rief W, Brunner E, Schmidt-Auberger S, Engel RR. Fluoxetine versus placebo: A double-blind study with bulimic inpatients undergoing intensive psychotherapy. Pharmacopsychiatry. 1991;24:1–7.
    1. Kanerva R, Rissanen A, Sarna S. Fluoxetine in the treatment of anxiety, depressive symptoms, and eating-related symptoms in bulimia nervosa. Nord J Psychiatry. 1994;49:237–242.
    1. Fichter MM, Kruger R, Rief W, Holland R, Dohne J. Fluvoxamine in prevention of relapse in bulimia nervosa: Effects on eating specific psychopathology. J Clin Psychopharmacol. 1996;16:9–18.
    1. Milano W, Petrella C, Sabatino C, Capasso A. Treatment of bulimia nervosa with sertraline: A randomized controlled trial. Adv Ther. 2004;21:232–7.
    1. Pope HG, Jr, Keck PE, Jr, McElroy SL, Hudson JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol. 1989;9:254–9.
    1. Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry. 1991;148:1206–12.
    1. Kennedy SH, Goldbloom DS, Ralevski E, Davis C, D’Souza JD, Lofchy J. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. J Clin Psychopharmacol. 1993;13:415–22.
    1. Bacaltchuk J, Hay P. Cochrane Database Syst Rev. 2003. Antidepressants versus placebo for people with bulimia nervosa; p. CD003391.
    1. Faris PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, et al. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: A randomised, double-blind trial. Lancet. 2000;355:792–7.
    1. Hsu LK, Clement L, Santhouse R, Ju ES. Treatment of bulimia nervosa with lithium carbonate: A controlled study. J Nerv Ment Dis. 1991;179:351–5.
    1. Fahy TA, Eisler I, Russell GF. A placebo-controlled trial of d-fenfluramine in bulimia nervosa. Br J Psychiatry. 1993;162:597–603.
    1. Alger SA, Schwalberg MD, Bigaouette JM, Michalek AV, Howard LJ. Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects. Am J Clin Nutr. 1991;53:865–71.
    1. Igoin-Apfelbaum L, Apfelbaum M. Naltrexone and bulimic symptoms. Lancet. 1987;2:1087–8.
    1. Mitchell JE, Christenson G, Jennings J, Huber M, Thomas B, Pomeroy C, et al. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia. J Clin Psychopharmacol. 1989;9:94–7.
    1. Hedges DW, Reimherr FW, Hoopes SP, Rosenthal NR, Kamin M, Karim R, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo controlled trial, part 2: Improvement in psychiatric measures. J Clin Psychiatry. 2003;64:1449–54.
    1. Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: Improvement in binge and purge measures. J Clin Psychiatry. 2003;64:1335–41.
    1. Anderson CB, Joyce PR, Carter FA, McIntosh VV, Bulik CM. The effect of cognitive-behavioral therapy for bulimia nervosa on temperament and character as measured by the temperament and character inventory. Compr Psychiatry. 2002;43:182–8.
    1. Agras WS, Walsh T, Fairburn CG, Wilson GT, Kraemer HC. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa. Arch Gen Psychiatry. 2000;57:459–66.
    1. Fairburn CG, Jones R, Peveler RC, Hope RA, O’Connor M. Psychotherapy and bulimia nervosa: Longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Arch Gen Psychiatry. 1993;50:419–28.
    1. Fairburn CG, Marcus MD, Wilson GT. Cognitive-behavioral therapy for binge eating and bulimia nervosa: a comprehensive treatment manual. In: Fairburn CG, Wilson GT, editors. Binge Eating: Nature, Assessment, and Treatment. New York: Guilford; 1993. pp. 361–404.
    1. Garner DM, Rockert W, Davis R, Garner MV, Olmsted MP, Eagle M. Comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa. Am J Psychiatry. 1993;150:37–46.
    1. Mitchell JE, Pyle RL, Pomeroy C, Zollman M, Crosby R, Seim H, et al. Cognitive-behavioral group psychotherapy of bulimia nervosa: Importance of logistical variables. Int J Eat Disord. 1993;14:277–87.
    1. Vandereycken W. The addiction model in eating disorders: some critical remarks and a selected bibliography. Int J Eat Disord. 1990;9:95–102.
    1. Bulik CM, Sullivan PF, Carter FA, McIntosh VV, Joyce PR. The role of exposure with response prevention in the cognitive-behavioural therapy for bulimia nervosa. Psychol Med. 1998;28:611–23.
    1. Bulik CM, Sullivan PF, Joyce PR, Carter FA, McIntosh VV. Predictors of 1-year treatment outcome in bulimia nervosa. Compr Psychiatry. 1998;39:206–14.
    1. Davis R, McVey G, Heinmaa M, Rockert W, Kennedy S. Sequencing of cognitive-behavioral treatments for bulimia nervosa. Int J Eat Disord. 1999;25:361–74.
    1. Hsu LK, Rand W, Sullivan S, Liu DW, Mulliken B, McDonagh B, et al. Cognitive therapy, nutritional therapy and their combination in the treatment of bulimia nervosa. Psychol Med. 2001;31:871–9.
    1. Wilson GT, Fairburn CC, Agras WS, Walsh BT, Kraemer H. Cognitive-behavioral therapy for bulimia nervosa: Time course and mechanisms of change. J Consult Clin Psychol. 2002;70:267–74.
    1. Wilson GT, Loeb KL, Walsh BT, Labouvie E, Petkova E, Liu X, et al. Psychological versus pharmacological treatments of bulimia nervosa: Predictors and processes of change. J Consult Clin Psychol. 1999;67:451–9.
    1. Fairburn CG, Jones R, Peveler RC, Carr SJ, Solomon RA, O’Connor ME, et al. Three psychological treatments for bulimia nervosa: A comparative trial. Arch Gen Psychiatry. 1991;48:463–9.
    1. Wilfley DE, Agras WS, Telch CF, Rossiter EM, Schneider JA, Cole AG, et al. Group cognitive-behavioral therapy and group interpersonal psychotherapy for the nonpurging bulimic individual: A controlled comparison. J Consult Clin Psychol. 1993;61:296–305.
    1. Chen E, Touyz SW, Beumont PJ, Fairburn CG, Griffiths R, Butow P, et al. Comparison of group and individual cognitive-behavioral therapy for patients with bulimia nervosa. Int J Eat Disord. 2003;33:241–54.
    1. Cooper PJ, Steere J. A comparison of two psychological treatments for bulimia nervosa: Implications for models of maintenance. Behav Res Ther. 1995;33:875–85.
    1. Agras WS, Schneider JA, Arnow B, Raeburn SD, Telch CF. Cognitive-behavioral and response-prevention treatments for bulimia nervosa. J Consult Clin Psychol. 1989;57:215–21.
    1. Wolk SL, Devlin MJ. Stage of change as a predictor of response to psychotherapy for bulimia nervosa. Int J Eat Disord. 2001;30:96–100.
    1. Garner DM, Rockert W, Davis R, Garner M, Olmsted MP, Eagle M. Comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa. Am J Psychiatry. 1993;150:37–46.
    1. Sundgot-Borgen J, Rosenvinge JH, Bahr R, Schneider LS. The effect of exercise, cognitive therapy, and nutritional counseling in treating bulimia nervosa. Med Sci Sports Exerc. 2002;34:190–5.
    1. Schmidt U. Cognitive behavioral approaches in adolescent anorexia and bulimia nervosa. Child Adolesc Psychiatr Clin N Am. 2009;18:147–58.
    1. Safer DL, Telch CF, Agras WS. Dialectical behavior therapy for bulimia nervosa. Am J Psychiatry. 2001;158:632–4.
    1. Schwartz RC, Barett MJ, Saba G. New York: Guilford; 1985. Family therapy for bulimia.
    1. Bailer U, de Zwaan M, Leisch F, Strnad A, Lennkh-Wolfsberg C, El-Giamal N, et al. Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa. Int J Eat Disord. 2004;35:522–37.
    1. Carter JC, Olmsted MP, Kaplan AS, McCabe RE, Mills JS, Aime A. Self help for bulimia nervosa: A randomized controlled trial. Am J Psychiatry. 2003;160:973–8.
    1. Durand MA, King M. Specialist treatment versus self-help for bulimia nervosa: A randomised controlled trial in general practice. Br J Gen Pract. 2003;53:371–7.
    1. Thiels C, Schmidt U, Treasure J, Garthe R, Troop N. Guided self-change for bulimia nervosa incorporating use of a self-care manual. Am J Psychiatry. 1998;155:947–53.
    1. Schmidt U, Andiappan M, Grover M, Robinson S, Perkins S, Dugmore O, et al. Randomised controlled trial of CD-ROM-based cognitive-behavioural self-care for bulimia nervosa. Br J Psychiatry. 2008;193:493–500.
    1. Malenbaum R, Herzog D, Eisenthal S, Wyshak G. Overeaters Anonymous. Int J Eat Disord. 1988;7:139–44.
    1. Rorty M, Yager J, Rossotto E. Why and how do women recover from bulimia nervosa? The subjective appraisals of forty women recovered for a year or more. Int J Eat Disord. 1993;14:249–60.
    1. Hay PJ, Bacaltchuk J, Stefano S. Psychotherapy for bulimia nervosa and binging. Cochrane Database Syst Rev. 2004:CD000562.
    1. Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, et al. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. Am J Psychiatry. 1992;149:82–7.
    1. Agras WS, Rossiter EM, Arnow B, Telch CF, Raeburn SD, Bruce B, et al. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa. J Clin Psychiatry. 1994;55:179–83.
    1. Goldbloom DS, Olmsted M, Davis R, Clewes J, Heinmaa M, Rockert W, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: Short-term outcome. Behav Res Ther. 1997;35:803–11.
    1. Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry. 1997;154:523–31.
    1. Mitchell JE, Fletcher L, Hanson K, Mussell MP, Seim H, Crosby R, et al. The relative efficacy of fluoxetine and manual-based self help in the treatment of outpatients with bulimia nervosa. J Clin Psychopharmacol. 2001;21:298–304.
    1. Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry. 1997;154:523–31.
    1. Wilson GT, Loeb KL, Walsh BT, Labouvie E, Petkova E, Liu X, et al. Psychological versus pharmacological treatments of bulimia nervosa: Predictors and processes of change. J Consult Clin Psychol. 1999;67:451–9.
    1. Mitchell JE, Halmi K, Wilson GT, Agras WS, Kraemer H, Crow S, et al. A randomized secondary treatment study of women with bulimia nervosa who fail to respond to CBT. Int J Eat Disord. 2002;32:271–81.
    1. Bacaltchuk J, Hay P, Trefiglio R. Antidepressants versus psychological treatments and their combination for bulimia nervosa. Cochrane Database Syst Rev. 2001
    1. Esplen MJ, Garfinkel PE, Olmsted M, Gallop RM, Kennedy S. A randomized controlled trial of guided imagery in bulimia nervosa. Psychol Med. 1998;28:1347–57.
    1. Braun DL, Sunday SR, Fornari VM, Halmi KA. Bright light decreases winter binge frequency in women with bulimia nervosa: a double-blind, placebo controlled study. Compr Psychiatry. 1999;40:442–8.
    1. Mitchell JE, Agras WS, Wilson GT, Halmi K, Kraemer H, Crow S. A trial of a relapse prevention strategy in women with bulimia nervosa who respond to cognitive-behavior therapy. Int J Eat Disord. 2004;35:549–55.
    1. Fichter MM, Quadflieg N. Twelve-year course and outcome of bulimia nervosa. Psychol Med. 2004;34:1395–406.
    1. Fichter MM, Quadflieg N. Six-year course of bulimia nervosa. Int J Eat Disord. 1997;22:361–84.
    1. Fairburn CG, Cooper Z, Doll HA, Norman P, O’Connor M. The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry. 2000;57:659–65.
    1. Fairburn CG, Norman PA, Welch SL, O’Connor ME, Doll HA, Peveler RC. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry. 1995;52:304–12.
    1. Fairburn CG, Stice E, Cooper Z, Doll HA, Norman PA, O’Connor ME. Understanding persistence in bulimia nervosa: A 5-year naturalistic study. J Consult Clin Psychol. 2003;71:103–9.
    1. Stice E, Fairburn CG. Dietary and dietary-depressive subtypes of bulimia nervosa show differential symptom presentation, social impairment, comorbidity, and course of illness. J Consult Clin Psychol. 2003;71:1090–4.
    1. Keel PK, Mitchell JE, Miller KB, Davis TL, Crow SJ. Predictive validity of bulimia nervosa as a diagnostic category. Am J Psychiatry. 2000;157:136–8.
    1. Keel PK, Mitchell JE, Davis TL, Crow SJ. Relationship between depression and body dissatisfaction in women diagnosed with bulimia nervosa. Int J Eat Disord. 2001;30:48–56.
    1. van Son GE, van Hoeken D, van Furth EF, Donker GA, Hoek HW. Course and outcome of eating disorders in a primary care-based cohort. Int J Eat Disord. 2010;43:130–8.
    1. Vrabel KR, Ro O, Martinsen EW, Hoffart A, Rosenvinge JH. Five-year prospective study of personality disorders in adults with longstanding eating disorders. Int J Eat Disord. 2010;43:22–8.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren